WMS Partners LLC increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.9% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,557 shares of the medical research company’s stock after acquiring an additional 65 shares during the period. WMS Partners LLC’s holdings in Thermo Fisher Scientific were worth $1,009,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. State Street Corp raised its stake in shares of Thermo Fisher Scientific by 1.0% during the first quarter. State Street Corp now owns 16,503,764 shares of the medical research company’s stock valued at $4,684,029,000 after acquiring an additional 165,895 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Thermo Fisher Scientific by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 5,540,921 shares of the medical research company’s stock worth $1,795,964,000 after purchasing an additional 151,622 shares during the last quarter. Norges Bank bought a new position in Thermo Fisher Scientific in the fourth quarter worth approximately $1,411,603,000. Pictet Asset Management Ltd. raised its position in Thermo Fisher Scientific by 5.2% in the first quarter. Pictet Asset Management Ltd. now owns 2,774,089 shares of the medical research company’s stock worth $786,732,000 after acquiring an additional 137,370 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its position in Thermo Fisher Scientific by 30.6% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,217,273 shares of the medical research company’s stock worth $628,819,000 after acquiring an additional 519,525 shares during the period. Institutional investors own 87.65% of the company’s stock.

In related news, CEO Marc N. Casper sold 20,000 shares of Thermo Fisher Scientific stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $349.89, for a total transaction of $6,997,800.00. Following the completion of the transaction, the chief executive officer now directly owns 294,946 shares of the company’s stock, valued at approximately $103,198,655.94. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Marc N. Casper sold 30,000 shares of Thermo Fisher Scientific stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $333.02, for a total transaction of $9,990,600.00. Following the transaction, the chief executive officer now directly owns 304,946 shares of the company’s stock, valued at $101,553,116.92. The disclosure for this sale can be found here. Insiders sold a total of 97,500 shares of company stock valued at $33,044,350 over the last three months. Corporate insiders own 0.44% of the company’s stock.

NYSE TMO traded down $2.99 on Wednesday, reaching $347.10. The company had a trading volume of 77,490 shares, compared to its average volume of 1,322,261. The company has a quick ratio of 1.69, a current ratio of 2.32 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $137.97 billion, a PE ratio of 38.19, a price-to-earnings-growth ratio of 2.34 and a beta of 1.04. The firm’s 50 day moving average price is $334.77 and its 200 day moving average price is $319.93. Thermo Fisher Scientific Inc. has a 12 month low of $250.21 and a 12 month high of $351.86.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, April 22nd. The medical research company reported $2.94 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.15. Thermo Fisher Scientific had a net margin of 14.31% and a return on equity of 17.25%. The business had revenue of $6.23 billion during the quarter, compared to analysts’ expectations of $6.18 billion. During the same period last year, the company posted $2.81 EPS. The business’s revenue was up 1.7% on a year-over-year basis. On average, research analysts expect that Thermo Fisher Scientific Inc. will post 11.92 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Monday, June 15th will be paid a $0.22 dividend. The ex-dividend date of this dividend is Friday, June 12th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.25%. Thermo Fisher Scientific’s payout ratio is currently 7.13%.

TMO has been the topic of several recent research reports. Needham & Company LLC increased their price target on shares of Thermo Fisher Scientific from $341.00 to $383.00 in a research report on Thursday, April 23rd. Wells Fargo & Co raised their price objective on shares of Thermo Fisher Scientific from $300.00 to $340.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 21st. Robert W. Baird raised their price objective on shares of Thermo Fisher Scientific from $340.00 to $341.00 and gave the company an “outperform” rating in a research report on Wednesday, March 4th. Citigroup raised their price objective on shares of Thermo Fisher Scientific from $365.00 to $390.00 and gave the company a “buy” rating in a research report on Thursday, April 23rd. Finally, SVB Leerink raised their price objective on shares of Thermo Fisher Scientific from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, April 23rd. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $349.31.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: How to identify percentage decliners

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.